Cytology specimens offer an effective alternative to formalin-fixed tissue as demonstrated by novel automated detection for ALK break-apart FISH testing and immunohistochemistry in lung adenocarcinoma
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cytology specimens offer an effective alternative to formalin-fixed tissue as demonstrated by novel automated detection for ALK break-apart FISH testing and immunohistochemistry in lung adenocarcinoma
Authors
Keywords
-
Journal
CANCER CYTOPATHOLOGY
Volume 122, Issue 11, Pages 810-821
Publisher
Wiley
Online
2014-08-06
DOI
10.1002/cncy.21467
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anaplastic lymphoma kinase gene rearrangements in cytological samples of non-small cell lung cancer: Comparison with histological assessment
- (2014) Agnese Proietti et al. CANCER CYTOPATHOLOGY
- BRAF/KRAS gene sequencing of sebaceous neoplasms after mismatch repair protein analysis
- (2014) Kristine M. Cornejo et al. HUMAN PATHOLOGY
- ALK Status Testing in Non–Small-Cell Lung Carcinoma by FISH on ThinPrep Slides with Cytology Material
- (2014) Eugen C. Minca et al. Journal of Thoracic Oncology
- An International Interpretation Study Using the ALK IHC Antibody D5F3 and a Sensitive Detection Kit Demonstrates High Concordance between ALK IHC and ALK FISH and between Evaluators
- (2014) Murry W. Wynes et al. Journal of Thoracic Oncology
- Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology
- (2013) Neal I. Lindeman et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- The use of stained cytologic direct smears forALKgene rearrangement analysis of lung adenocarcinoma
- (2013) Bryan L. Betz et al. CANCER CYTOPATHOLOGY
- ALKrearrangements in EBUS-derived transbronchial needle aspiration cytology in lung cancer
- (2013) M. J. Neat et al. CYTOPATHOLOGY
- Detection of ALK-Positive Non–Small-Cell Lung Cancers on Cytological Specimens: High Accuracy of Immunocytochemistry with the 5A4 Clone
- (2013) Spasenija Savic et al. Journal of Thoracic Oncology
- Comparison of Reverse Transcription-Polymerase Chain Reaction, Immunohistochemistry, and Fluorescence In Situ Hybridization Methodologies for Detection of Echinoderm Microtubule-Associated Proteinlike 4–Anaplastic Lymphoma Kinase Fusion–Positive Non–Small Cell Lung Carcinoma: Implications for Optimal Clinical Testing
- (2012) Michelle L. Wallander et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- A case of lung adenocarcinoma harboring EGFR mutation and EML4-ALKfusion gene
- (2012) Hisashi Tanaka et al. BMC CANCER
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Diagnostic assays for identification of anaplastic lymphoma kinase-positive non-small cell lung cancer
- (2012) Andrew J. Weickhardt et al. CANCER
- Ancillary techniques on direct-smear aspirate slides
- (2012) Stewart M. Knoepp et al. CANCER CYTOPATHOLOGY
- Crizotinib for ALK-Rearranged Non-Small Cell Lung Cancer: A New Targeted Therapy for a New Target
- (2012) L. Gandhi et al. CLINICAL CANCER RESEARCH
- Respiratory cytology in the era of molecular diagnostics: A review
- (2012) Benjamin L. Witt et al. DIAGNOSTIC CYTOPATHOLOGY
- Molecular diagnostics and personalized medicine in oncology: Challenges and opportunities
- (2012) Nicola Normanno et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Clinicopathologic and Molecular Characteristics of Lung Adenocarcinoma Arising in Young Patients
- (2012) Lucia Kim et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- A Dramatic Response to Crizotinib in a Non–Small-Cell Lung Cancer Patient with IHC-Positive and FISH-Negative ALK
- (2012) Jong-Mu Sun et al. Journal of Thoracic Oncology
- Immunohistochemistry is a Reliable Screening Tool for Identification of ALK Rearrangement in Non–Small-Cell Lung Carcinoma and is Antibody Dependent
- (2012) Chris M.J. Conklin et al. Journal of Thoracic Oncology
- Histologic and cytomorphologic features of ALK-rearranged lung adenocarcinomas
- (2012) Michiya Nishino et al. MODERN PATHOLOGY
- EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendations
- (2012) Erik Thunnissen et al. VIRCHOWS ARCHIV
- Diagnostic Usefulness of Tumor Markers in the Thyroid Cytological Samples Extracted by Fine-Needle Aspiration Biopsy
- (2012) Jose Gomez Saez Endocrine Metabolic & Immune Disorders-Drug Targets
- Targeting Anaplastic Lymphoma Kinase in Lung Cancer
- (2011) A. T. Shaw et al. CLINICAL CANCER RESEARCH
- Subtyping of Non-small Cell Lung Carcinoma: A Comparison of Small Biopsy and Cytology Specimens
- (2011) Carlie S. Sigel et al. Journal of Thoracic Oncology
- International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
- (2011) William D. Travis et al. Journal of Thoracic Oncology
- Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis
- (2011) Alice T Shaw et al. LANCET ONCOLOGY
- A Novel, Highly Sensitive Antibody Allows for the Routine Detection of ALK-Rearranged Lung Adenocarcinomas by Standard Immunohistochemistry
- (2010) M. Mino-Kenudson et al. CLINICAL CANCER RESEARCH
- Cytology-based gene mutation tests to predict response to anti-epidermal growth factor receptor therapy: A review
- (2010) Umberto Malapelle et al. DIAGNOSTIC CYTOPATHOLOGY
- The biology and treatment of EML4-ALK non-small cell lung cancer
- (2010) Takaaki Sasaki et al. EUROPEAN JOURNAL OF CANCER
- The Prognostic and Predictive Role of Histology in Advanced Non-small Cell Lung Cancer: A Literature Review
- (2010) Fred R. Hirsch et al. Journal of Thoracic Oncology
- Consensus for EGFR Mutation Testing in Non-small Cell Lung Cancer: Results from a European Workshop
- (2010) Robert Pirker et al. Journal of Thoracic Oncology
- Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression
- (2010) Xuchao Zhang et al. Molecular Cancer
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
- (2010) Eunice L. Kwak et al. NEW ENGLAND JOURNAL OF MEDICINE
- Histologic Considerations for Individualized Systemic Therapy Approaches for the Management of Non-small Cell Lung Cancer
- (2009) Howard West et al. CHEST
- Unique Clinicopathologic Features Characterize ALK-Rearranged Lung Adenocarcinoma in the Western Population
- (2009) S. J. Rodig et al. CLINICAL CANCER RESEARCH
- EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology and young onset
- (2009) Kentaro Inamura et al. MODERN PATHOLOGY
- Identification of Novel Isoforms of the EML4-ALK Transforming Gene in Non-Small Cell Lung Cancer
- (2008) Y. L. Choi et al. CANCER RESEARCH
- EML4-ALK Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer
- (2008) J. P. Koivunen et al. CLINICAL CANCER RESEARCH
- Lung adenocarcinoma: guiding EGFR-targeted therapy and beyond
- (2008) Marc Ladanyi et al. MODERN PATHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search